ABMD Historical PE Ratio image   This ABMD PE ratio history page last updated 1/5/2023
ABMD PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2023
11/1/2022
377.821.304.8478.1
Q1 2023
8/4/2022
292.241.254.5763.9
Q4 2022
4/28/2022
287.221.164.4265.0
Q3 2022
2/3/2022
290.521.134.5064.6
Q2 2022
10/28/2021
343.141.034.7272.7
Q1 2022
8/4/2021
331.201.104.7070.5
Q4 2021
4/29/2021
322.941.244.1877.3
Q3 2021
1/28/2021
355.131.353.9490.1
Q2 2021
10/29/2020
254.611.013.7168.6
Q1 2021
8/6/2020
314.980.583.7384.4
Q4 2020
4/30/2020
191.251.004.1546.1
Q3 2020
2/6/2020
196.011.124.2446.2
Q2 2020
10/31/2019
207.581.034.0950.8
Q1 2020
8/1/2019
204.871.003.8752.9
Q4 2019
5/2/2019
264.771.093.6572.5
Q3 2019
1/31/2019
351.070.973.36104.5
Q2 2019
11/1/2018
376.940.813.09122.0
Q1 2019
7/26/2018
384.210.782.72141.3
Q4 2018
5/3/2018
335.570.802.39140.4
Q3 2018
2/1/2018
253.130.701.99127.2
Q2 2018
10/26/2017
179.590.441.63110.2
Q1 2018
7/27/2017
142.970.451.39102.9
Q4 2017
5/4/2017
130.810.401.23106.3
Q3 2017
1/26/2017
106.090.341.0799.1
Q2 2017
10/27/2016
103.320.200.96107.6
Q1 2017
7/28/2016
115.030.290.93123.7
Q4 2016
5/3/2016
98.900.240.84117.7
Q3 2016
2/4/2016
92.000.230.88104.5
Q2 2016
10/29/2015
70.400.170.9574.1
Q1 2016
8/4/2015
88.800.200.87102.1
Q4 2015
5/5/2015
75.470.280.63119.8
Q3 2015
1/27/2015
38.630.300.4487.8
Q2 2015
10/30/2014
31.350.090.25125.4
Q1 2015
7/31/2014
25.60-0.040.19134.7
Q4 2014
5/1/2014
22.660.090.19119.3
Q3 2014
1/30/2014
26.930.110.20134.6
Q2 2014
11/6/2013
25.840.030.16161.5
Q1 2014
8/1/2013
24.15-0.040.3373.2
Q4 2013
5/2/2013
19.880.100.5337.5
Q3 2013
2/6/2013
13.540.070.5624.2
Q2 2013
11/1/2012
13.610.200.4629.6
Q1 2013
8/2/2012
22.830.16NANA
Q4 2012
5/16/2012
23.220.13NANA
Q1 2012
8/4/2011
12.05-0.03NANA
ABMD Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2023
11/1/2022
377.821.305.2072.7
Q1 2023
8/4/2022
292.241.255.0058.4
Q4 2022
4/28/2022
287.221.164.6461.9
Q3 2022
2/3/2022
290.521.134.5264.3
Q2 2022
10/28/2021
343.141.034.1283.3
Q1 2022
8/4/2021
331.201.104.4075.3
Q4 2021
4/29/2021
322.941.244.9665.1
Q3 2021
1/28/2021
355.131.355.4065.8
Q2 2021
10/29/2020
254.611.014.0463.0
Q1 2021
8/6/2020
314.980.582.32135.8
Q4 2020
4/30/2020
191.251.004.0047.8
Q3 2020
2/6/2020
196.011.124.4843.8
Q2 2020
10/31/2019
207.581.034.1250.4
Q1 2020
8/1/2019
204.871.004.0051.2
Q4 2019
5/2/2019
264.771.094.3660.7
Q3 2019
1/31/2019
351.070.973.8890.5
Q2 2019
11/1/2018
376.940.813.24116.3
Q1 2019
7/26/2018
384.210.783.12123.1
Q4 2018
5/3/2018
335.570.803.20104.9
Q3 2018
2/1/2018
253.130.702.8090.4
Q2 2018
10/26/2017
179.590.441.76102.0
Q1 2018
7/27/2017
142.970.451.8079.4
Q4 2017
5/4/2017
130.810.401.6081.8
Q3 2017
1/26/2017
106.090.341.3678.0
Q2 2017
10/27/2016
103.320.200.80129.1
Q1 2017
7/28/2016
115.030.291.1699.2
Q4 2016
5/3/2016
98.900.240.96103.0
Q3 2016
2/4/2016
92.000.230.92100.0
Q2 2016
10/29/2015
70.400.170.68103.5
Q1 2016
8/4/2015
88.800.200.80111.0
Q4 2015
5/5/2015
75.470.281.1267.4
Q3 2015
1/27/2015
38.630.301.2032.2
Q2 2015
10/30/2014
31.350.090.3687.1
Q1 2015
7/31/2014
25.60-0.04-0.16NA
Q4 2014
5/1/2014
22.660.090.3662.9
Q3 2014
1/30/2014
26.930.110.4461.2
Q2 2014
11/6/2013
25.840.030.12215.3
Q1 2014
8/1/2013
24.15-0.04-0.16NA
Q4 2013
5/2/2013
19.880.100.4049.7
Q3 2013
2/6/2013
13.540.070.2848.4
Q2 2013
11/1/2012
13.610.200.8017.0
Q1 2013
8/2/2012
22.830.160.6435.7
Q4 2012
5/16/2012
23.220.130.5244.7
Q1 2012
8/4/2011
12.05-0.03-0.12NA
Quotes delayed 20 minutes

Email EnvelopeFree ABMD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Abiomed (ABMD) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ABOS PE Ratio History
ABSI PE Ratio History
ABT PE Ratio History
ABVC PE Ratio History
ACAD PE Ratio History
ACCD PE Ratio History
ACER PE Ratio History
ACET PE Ratio History
ACHC PE Ratio History
ACHV PE Ratio History
On this page we presented the ABMD PE Ratio History information for Abiomed' stock. The average ABMD PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 78.9. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ABMD PE ratio history based on this TTM earnings result method is 91.1. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ABMD PE ratio history result, against the recent PE: when this page was posted on 12/22/2022, the most recent closing price for ABMD had been 381.02, and the most recent quarterly earnings result, annualized, was 5.2. Meanwhile, the most recent TTM earnings summed to 4.84. From these numbers, we calculate the recent ABMD PE on 12/22/2022 based on annualized quarterly EPS was 73.3. Based on ABMD's history, that recent PE is low relative to the historical average, with the recent PE 7.1% lower than the historical average PE across our data set for Abiomed. Looking at the recent ABMD PE on 12/22/2022 based on TTM EPS, we calculate the ratio at 78.7. Based on ABMD's history, that recent PE is low relative to the historical average, with the recent PE 13.6% lower than the average PE across our Abiomed data set with TTM EPS used in the calculation at each period.

Another interesting ABMD PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for ABMD, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for ABMD, we start with the past four EPS numbers and we first sort them from lowest to highest: 1.13, 1.16, 1.25, and 1.30. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 1.16 and 1.25 — which gives us the median of 1.21. Basically the way to think about this 1.21 number is this: for the trailing four earnings reports, 1.21 marks the "middle ground" number where ABMD has reported a value higher than 1.21 half the time, and has reported a value lower than 1.21 half the time. Annualizing that median value then gets us to 4.84/share, which we use as the denominator in our next PE calculation. With 381.02 as the numerator (as of 12/22/2022), the calculation is then 381.02 / 4.84 = 78.7 as the ABMD PE ratio as of 12/22/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on ABMD or any other given stock, valuation analysis for ABMD can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Abiomed PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for ABMD. Thanks for visiting, and the next time you need to research ABMD PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: EQU Split History, NFLX Average Annual Return, Top Ten Hedge Funds Holding PNRL.

 

ABMD PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2023, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.